เกี่ยวกับตอนนี้
Leo Petrossian, CEO of Kandu, discusses a groundbreaking approach to stroke recovery that uses an FDA-cleared, non-invasive EEG headset combined with a robotic glove that detects when a patient visualizes moving their impaired arm and simultaneously moves the arm mechanically. Traditional rehabilitation has treated the arm rather than the brain, which is the source of the damage. This brain-computer interface builds new neuronal pathways and has proven effective in chronic stroke patients, regardless of how much time has passed since the stroke.
Leo explains, "When we think of Kandu, we think of it in many dimensions. It may be described as a technology company or a startup or an innovative organization or things like that. I often don't view it through the lens of the company. I rotate the narrative and focus on the patient population that we serve. Kandu is really the story of eight million patients living in the United States who are currently almost invisible to the healthcare system. There are about eight million stroke survivors living in the United States, and these people have had to figure out what it means to live a life again after suffering a significant health event."
"Because it's very challenging and stressful, less than half of the patients who are disabled actually get into rehab in that 90 to 180-day window. And most patients pass that 180-day line, never even having a chance to restore lost function. So IpsiHand is an FDA-designated breakthrough therapy that was de novo cleared, which is a novel technology. It's the first and only thought-activated therapy ever cleared by the FDA."
#Kandu #StrokeRehabilitation #BrainComputerInterface #BCI #ChronicStroke #MedTech #Neurology #ClinicalInnovation #OccupationalTherapy #PhysicalTherapy #HealthcareInnovation #StrokeRecovery #StrokeSurvivor #Neuroplasticity #NeuroRehabilitation
